matrix metalloproteinase 2

Preferred Label : matrix metalloproteinase 2;

MeSH definition : A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.;

MeSH synonym : gelatinase a; metalloproteinase, mmp-2; metalloproteinase 2, matrix; 72 kda gelatinase; 72-kda type iv collagenase; mmp2 metalloproteinase; metalloproteinase, mmp2; 72 kda type iv collagenase; 72-kda gelatinase; gelatinase, 72-kda; mmp-2 metalloproteinase; mmp 2 metalloproteinase; matrix Metalloproteinase-2;

Registry Number MeSH : EC 3.4.24.24;

MeSH annotation : /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-2 is available;

Wikipedia link : https://en.wikipedia.org/wiki/Gelatinase a;

Is substance : O;

UNII : EC 3.4.24.24;

Details

Origin ID

D020778;

UMLS CUI

C0172537;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- (diethyl((methylsulfinyl)methyl)phosphonate)(dimethylmalonato)platinum(II) [MeSH Supplementary Concept]
- 2-((4-biphenylsulfonyl)amino)-3-phenylpropionic acid [MeSH Supplementary Concept]
- 3-methyl-2-(4-(3-p-tolyl(1,2,4)oxadiazol-5-yl)benzenesulfonylamino)butyric acid [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-3-cyclohexylpropyl-4,7-dioxo-7-(phenylethylamino)heptanohydroxamic acid [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-4,7-dioxo-7-(phenylethylamino)-3-phenylpropylheptanohydroxamic acid [MeSH Supplementary Concept]
- LY52 compound [MeSH Supplementary Concept]
- MAG 283 [MeSH Supplementary Concept]
- N-hydroxy-2-((4-phenylphenyl)sulfonylpropan-2-yloxyamino)acetamide [MeSH Supplementary Concept]
- N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide [MeSH Supplementary Concept]
- YLL 224 [MeSH Supplementary Concept]
- dichloro(diethyl((methylsulfinyl)methyl)phosphonate)platinum(II) [MeSH Supplementary Concept]
- methyl 6-(benzyloxycarbonylamino)-2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)hexanoate [MeSH Supplementary Concept]
Record concept(s)
- matrix metalloproteinase 2 [MeSH concept]
Related MeSH Supplementary Concept(s)
- Col-1 peptide, human [MeSH Supplementary Concept]
- MMP2 protein, human [MeSH Supplementary Concept]
- Mmp2 protein, mouse [MeSH Supplementary Concept]
- Mmp2 protein, rat [MeSH Supplementary Concept]
Related MeSH term(s)
- matrix metalloproteinase inhibitors [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
UMLS correspondences (same concept)
- 72 kDa Type IV Collagenase [NCIt concept]
- Gelatinase A (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients